• 1. An approach towards the synthesis of novel fused nitrogen tricyclic heterocyclic scaffolds via GBB reaction?
  Sandip Gangadhar Balwe,Yeon Tae Jeong Org. Biomol. Chem., 2018,16, 1287-1296
• 2. Aggregation-induced chiroptical generation and photoinduced switching of achiral azobenzene-alt-fluorene copolymer endowed with left- and right-handed helical polysilanes?
  Hailing Chen,Lu Yin,Meng Liu,Laibing Wang,Michiya Fujiki,Wei Zhang RSC Adv., 2019,9, 4849-4856
• 3. An investigation of surface properties, local elastic modulus and interaction with simulated pulmonary surfactant of surface modified inhalable voriconazole dry powders using atomic force microscopy
  Michael Kappl,Paul M. Young,Daniela Traini,Sanyog Jain RSC Adv., 2016,6, 25789-25798
• 4. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 5. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543

• Solvents and Organic Chemicals Organic Compounds Hydrocarbons Saturated hydrocarbons Alkanes

Introduction to Non-8-ynyl-carbamic acid tert-butyl ester (CAS No. 1903797-81-8)

Non-8-ynyl-carbamic acid tert-butyl ester is a significant compound in the field of pharmaceutical chemistry, characterized by its unique structural and functional properties. This compound, identified by the CAS number 1903797-81-8, has garnered considerable attention due to its potential applications in drug development and synthetic organic chemistry. The presence of a terminal alkyne group and a tert-butyl ester moiety makes it a versatile intermediate for various chemical transformations, particularly in the synthesis of complex molecules.

The structure of Non-8-ynyl-carbamic acid tert-butyl ester features a linear backbone with a triple bond at the 8-position, which is a critical feature for its reactivity. This alkyne functionality allows for diverse chemical modifications, including cross-coupling reactions such as Suzuki-Miyaura, Heck, and Sonogashira couplings. These reactions are pivotal in constructing biaryl systems, which are prevalent in many pharmacologically active compounds. The tert-butyl ester group not only provides stability to the molecule but also serves as a protecting group for carboxylic acid functionalities, enabling selective modifications during synthetic pathways.

In recent years, there has been growing interest in exploring the applications of Non-8-ynyl-carbamic acid tert-butyl ester in medicinal chemistry. Its unique structural attributes make it an excellent candidate for developing novel therapeutic agents. For instance, the terminal alkyne can be functionalized to introduce various pharmacophores, while the ester group can be hydrolyzed to yield a free carboxylic acid, which can be further derivatized. This flexibility has led to its incorporation in several research projects aimed at discovering new drugs targeting various diseases.

One of the most compelling aspects of Non-8-ynyl-carbamic acid tert-butyl ester is its role as a building block in the synthesis of complex organic molecules. The synthetic utility of this compound has been demonstrated in multiple studies, where it has been employed to construct intricate scaffolds found in natural products and drug candidates. For example, researchers have utilized this compound to develop novel inhibitors of enzymes involved in cancer metabolism. The ability to precisely modify its structure has opened up new avenues for drug discovery and development.

The chemical properties of Non-8-ynyl-carbamic acid tert-butyl ester also make it an attractive candidate for material science applications. Its ability to undergo controlled polymerization reactions has been explored in the development of advanced materials with tailored properties. These materials could find applications in electronics, coatings, and biodegradable polymers. The versatility of this compound underscores its importance not only in pharmaceuticals but also in broader chemical research.

Recent advancements in synthetic methodologies have further enhanced the utility of Non-8-ynyl-carbamic acid tert-butyl ester. Techniques such as transition-metal-catalyzed reactions have made it possible to introduce diverse functional groups with high efficiency and selectivity. This has enabled chemists to design more complex molecules with precision, accelerating the discovery of new drugs and materials. The integration of computational chemistry and machine learning has also played a significant role in optimizing synthetic routes, making processes more efficient and sustainable.

The pharmacological potential of derivatives of Non-8-ynyl-carbamic acid tert-butyl ester has been extensively studied. Researchers have focused on developing analogs with improved bioavailability and reduced toxicity. By leveraging structure-activity relationship (SAR) studies, scientists have been able to fine-tune the properties of these compounds to enhance their therapeutic efficacy. This approach has led to several promising candidates that are currently undergoing further investigation.

In conclusion, Non-8-ynyl-carbamic acid tert-butyl ester (CAS No. 1903797-81-8) is a multifaceted compound with significant implications in pharmaceutical chemistry and material science. Its unique structural features and synthetic versatility make it an invaluable tool for researchers seeking to develop novel therapeutic agents and advanced materials. As our understanding of chemical transformations continues to evolve, the potential applications of this compound are likely to expand even further, driving innovation across multiple scientific disciplines.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)